Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical formulations such as hematinics, anti bacterials, gynecology, etc
Medley Pharmaceuticals Limited, is an unlisted public company incorporated on 15 April, 1975. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 33.00 cr and the total paid-up capital is INR 30.76 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
3.1%
17.89%
96.73%
15.51%
-100.0%
11.61%
1.16
3.03
8.26
7.75
3.38
-0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(25)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
DEUTSCHE BANK A.G.
No. of Loans: 1
Total Amount : 20.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 17.3 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Sahir Sami Khatib
Shareholder
|
00043681 | 10 years |
| Whole-time Director | Sarosh Sami Khatib
Shareholder
|
00058143 | 37 years |
| Director | Saba Mir Asif Ali
Shareholder
|
00058184 | 10 years |
| Whole-time Director | Mir Asif Ali | 00058250 | 25 years |
| Director | Suhel Sami Khatib
Shareholder
|
00904454 | 15 years |
| CS | Ravindra Baliram More | <HIDDEN> | 10 years |
| Director | Mohamed Aslam Abdul Rahman Sheikh | 03215349 | 0 years |
| Director | Sucheta Mudgerikar | 10720060 | 0 years |
| CFO | Devendra Pandurang Bhagat | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MEDLEY LABORATORIES PRIVATE LIMITED |
Amalgamated
|
13.0 L | 2 | Maharashtra |
| VIVOMED LABORATORIES PRIVATE LIMITED |
Active
|
4.4 L | 2 | Maharashtra |
| SINKHAI VENTURES PRIVATE LIMITED |
Active
|
5.3 L | 1 | Maharashtra |
| MINAR CHEMICALS PVT LTD |
Active
|
19.8 L | 2 | Maharashtra |
| SORBO MONNI CHEMICALS PRIVATE LIMITED |
Active
|
71.0 L | 2 | Maharashtra |
| STANDARD PRECIOUS ALLOY INDUSTRIES PRIVA TE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| SINKHAI INVESTMENTS PVT LTD |
Active
|
72.8 L | 1 | Maharashtra |
| MASIHA MEDICA PVT LTD |
Active
|
6.2 L | 1 | Maharashtra |
| BIOGEN LABORATORIES (INDIA) PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SINKHAI LEATHERS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| ORYX FISHERIES PRIVATE LIMITED |
Active
|
20.0 L | 1 | Maharashtra |
| BLUE-FIN FROZEN FOODS PRIVATE LIMITED |
Active
|
14.8 Cr | 1 | Maharashtra |
| SINKHAI HEALTHCARE LIMITED |
Active
|
4.0 Cr | 2 | Maharashtra |
| STERANCO HEALTHCARE PRIVATE LIMITED |
Active
|
99.0 L | 1 | Maharashtra |
| CHANNELS MEDICAL SYSTEMS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SINKHAI HEALTHCARE LIMITED | Maharashtra | 2005 | ₹ 4.0 Cr |
| MEDLEY PHARMA LIMITED | United Kingdom | - | - |
| LIMITED LIABILITY COMPANY MEDLEY PHARMACEUTICALS | Russia | - | - |
The incorporation date of MEDLEY PHARMACEUTICALS LIMITED is 15 April, 1975
The authorized share capital of MEDLEY PHARMACEUTICALS LIMITED is INR ₹ 33.0 Cr.
The paid-up capital of MEDLEY PHARMACEUTICALS LIMITED is INR ₹ 30.8 Cr.
The registered address of MEDLEY PHARMACEUTICALS LIMITED is MEDLEY HOUSED 2 M I D C AREA ANDHERI (EAST) MUMBAI Maharashtra - 400093
The CIN number of MEDLEY PHARMACEUTICALS LIMITED is U24230MH1975PLC018296.
Expand
Delete
Collapse
See
details
